Indeed, antibody blockade of CLEC14A interactions with its natural ligand, the endothelial‐specific extracellular matrix protein multimerin‐2, reduces angiogenesis and tumour growth in a mouse model [5]. This evidence concerns the gene CLEC14A and neoplasm.